USX:ROKA - Roka Bioscience Inc (USD 0.65) Roka Bioscience Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance
Note: This stock seems to be inactive

USD 0.65    -0.020 (-2.97%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

28 Dec 2017


28 Dec 2017

Day Change: -0.020 (-2.97%)

52 Wk Range: 0.6001 - 6.2

Day's Range: 0.65 - 0.69

Last Volume: 242,292

Current Yield: 0%

Projected Yield: 0%

Open: USD 0.6844

2 Aug 2018

Metric ROKA S.Median
Beta NA 0.78
VaR NA 21.09
E.Shortfall NA 29.34
Liquidity NA 92.34K


28 Dec 2017

PE: -0.099

Market Cap: 3.2M

Price Over Book: 0.26

Price Over Sales: 0.41

Return On Assets: -165.3%

Return On Equity: -262.9%

Price Over NAV: [Friends Only]


CEO: Mary Duseau

Headquarters: WARREN

Employees: 90

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing laboratories, and government regulatory authorities. The company was founded in 2009 and is headquartered in Warren, New Jersey.